Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.

Clain, Jeremy M; Cartin-Ceba, Rodrigo; Fervenza, Fernando C; Specks, Ulrich

Clain, Jeremy M; Cartin-Ceba, Rodrigo; Fervenza, Fernando C; Specks, Ulrich.

Afiliação

Clain JM; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Cartin-Ceba R; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Fervenza FC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Specks U; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Ther Adv Musculoskelet Dis ; 6(2): 58-74, 2014 Apr.

Article em En | MEDLINE | ID: mdl-24688606

Palavras-chave

antineutrophil cytoplasmic antibody; antineutrophil cytoplasmic antibody associated vasculitis; eosinophilic granulomatosis with polyangiitis (ChurgStrauss syndrome); granulomatosis with polyangiitis (Wegener's granulomatosis); microscopic polyangiitis; rituximab; vasculitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article